Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04039139
Other study ID # 2018P000578
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 30, 2019
Est. completion date April 20, 2020

Study information

Verified date January 2023
Source Beth Israel Deaconess Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Chronic pain syndromes without identified organic etiology remain a challenge for physicians. Many syndromes, including back pain, are believed to have potential underlying psychological etiology; however, the exact link remains elusive. The goal of this study is to determine if mind body therapies can help people suffering from chronic back pain. The study is a randomized, partially blinded trial examining the effectiveness of Mind Body Syndrome Therapy (MBST) in reducing disability from back pain and alleviating back pain. The investigators will secondarily investigate whether MBST can improve participant quality of life and reduce the need for pain-related hospitalization. The design of the this study consists of 3 arms with one being the intervention (MBST), one being usual care, and one being a second mind-body intervention (active control). This education program consists of a series of personal interviews and group and/or individualized lectures/sessions. Participants will also be provided reading material to study during the intervention period, and asked to continue their usual care while going through the MBST program.


Recruitment information / eligibility

Status Completed
Enrollment 35
Est. completion date April 20, 2020
Est. primary completion date April 20, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Adult patient 18 > years old - Chronic back pain - Pain persistent for =3 days/week for the past 3 months prior to enrollment - Willingness to consider mind-body intervention Exclusion Criteria: - Patients < 18 years of age - Diagnosed organic disease as cause of pain, such as (but not limited) to malignancy, neurologic disorder (i.e., amyotrophic lateral sclerosis), cauda equina syndrome. Pain related to disc disease is not an exclusion unless there are neurological impairments. - Patients with a diagnosis of significant psychiatric co-morbidities such as schizophrenia, dementia and bipolar disorder.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Mind Body Intervention 1: Mind-Body-Syndrome-Therapy (MBST)
Mind body techniques for Intervention 1 will be taught in lectures and group discussion sessions.
Mind Body Intervention 2
Mind body techniques for Intervention 2 will be taught in lectures and group and/or individual sessions.

Locations

Country Name City State
United States Beth Israel Deaconess Medical Center Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Beth Israel Deaconess Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain Disability: Roland Morris Disability Index Change in the Roland Morris Disability Index (Scale 0-24 with 24 being worst) change over 26 weeks
Secondary Average Pain: Brief Pain Inventory Survey Average pain as determined in the Brief Pain Inventory Survey (Scale 0-10 with 10 being worst) 4 weeks, 8 weeks, 13, weeks, 26 weeks
Secondary Pain Bothersomeness (Back Specific): Brief Pain Inventory Survey Back pain bothersomeness as determined from modified Brief Pain Inventory Survey. (Scale 0-10 with 10 being the worst) 4 weeks, 8 weeks, 13 weeks, 26 weeks
Secondary Pain Bothersomeness: Brief Pain Inventory Survey Whole-body pain bothersomeness as determined from modified Brief Pain Inventory Survey (Scale of 0-10 with 10 being the worst) 4 weeks, 8 weeks, 13 weeks, 26 weeks
Secondary Pain affecting enjoyment of life Scale 0-10 with 10 being worst from Brief Pain Inventory 4 weeks, 8 weeks, 13 weeks, 26 weeks
Secondary Anxiety from pain: Pain Anxiety Symptom Scale-20 survey Anxiety from pain as determined from the Pain Anxiety Symptom Scale-20 survey (20 questions with scale of 0-5 with 5 being 'always' and 0 being 'never' 4 weeks, 8 weeks, 13 weeks, 26 weeks
Secondary Pain-related hospital admissions Self reported. Number of pain-related hospital admissions, including emergency room visits 26 weeks
Secondary Complete resolution of pain disability: Roland Morris Disability complete resolution of pain disability as measured by Roland Morris Disability (Scale 0-24 with 24 being worst) 4 weeks, 8 weeks, 13 weeks, 26 weeks
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain